Literature DB >> 9699130

Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal.

P Harrer1, M Broecker, A Zint, H Schatz, V Zumtobel, M Derwahl.   

Abstract

Not only thyroid adenomas and carcinomas, but also the majority of single and well delimited goiter nodules, even if morphologically heterogeneous, are of clonal origin. However, it is still unknown whether the nodules of rapidly growing, recurrent goiters are clonal or polyclonal. We investigated by PCR-based analysis of exon 1 of the human androgen receptor gene clonality of nodules grown in recurrent multinodular goiters (MNG) of 14 female patients. The total goiter volume varied widely between 15 ml and 170 ml. The mean age of patients undergoing surgery for recurrent goiter at the time of their first operation was significantly lower with 34.6 +/- 10.9 yr in comparison to 50 consecutive patients who were operated for MNG for the first time (53.7 +/- 13.5 yr). The interval between first and recurrent operation was 18 +/- 8.5 yr. The mean volume of well circumscribed nodules selected for the present investigation was 3.8 +/- 1.4 ml. Assessment of clonality in at least 2 samples of each lesion revealed a polyclonal pattern in 10 out of 14 nodules, whereas only 3 nodules were clonal and in one case the result remained unclear. The unexpected finding that most nodules within MNG, that had re-grown after a first subtotal thyroidectomy, were of polyclonal rather than clonal composition, suggests that these lesions are generated by de novo-proliferation of cohorts of differing thyrocytes sharing the common trait of an exceedingly high intrinsic growth rate or alternatively, by unknown growth stimulating molecular events acting focally on clusters of cells derived from different ancestors. In addition, the relatively young age of patients with recurrent MNG at the time of their first surgery and the comparatively short interval between first and second operation point to a genetic element in the occurrence of growth-prone thyrocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699130     DOI: 10.1007/BF03350774

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

Review 1.  Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth.

Authors:  H Studer; H J Peter; H Gerber
Journal:  Endocr Rev       Date:  1989-05       Impact factor: 19.871

2.  TGF-beta 1 immunohistochemistry in goiter: comparison of patients with recurrence or no recurrence.

Authors:  P P Morosini; A Taccaliti; R Montironi; M Scarpelli; L Diamanti; G Simonella; V Mancini; M D Petrelli; F Mantero
Journal:  Thyroid       Date:  1996-10       Impact factor: 6.568

3.  High long term recurrence rate after subtotal thyroidectomy for nodular goitre.

Authors:  J Röjdmark; J Järhult
Journal:  Eur J Surg       Date:  1995-10

4.  Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue.

Authors:  F Minuto; A Barreca; P Del Monte; G Cariola; G C Torre; G Giordano
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

5.  Effectiveness of prophylactic therapy on goiter recurrence in an area with low iodine intake--a sonographic follow-up study.

Authors:  A H Rzepka; K Cissewski; T Olbricht; D Reinwein
Journal:  Clin Investig       Date:  1994-12

Review 6.  Mechanisms of nonneoplastic endocrine hyperplasia--a changing concept: a review focused on the thyroid gland.

Authors:  H Studer; M Derwahl
Journal:  Endocr Rev       Date:  1995-08       Impact factor: 19.871

7.  Molecular genetics of thyroid cancer.

Authors:  D Wynford-Thomas
Journal:  Trends Endocrinol Metab       Date:  1993-09       Impact factor: 12.015

8.  Morphological and functional polymorphism within clonal thyroid nodules.

Authors:  S Aeschimann; P A Kopp; E T Kimura; J Zbaeren; A Tobler; M F Fey; H Studer
Journal:  J Clin Endocrinol Metab       Date:  1993-09       Impact factor: 5.958

9.  Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters.

Authors:  P Kopp; E T Kimura; S Aeschimann; M Oestreicher; A Tobler; M F Fey; H Studer
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

10.  Clonal composition of benign and malignant human thyroid tumors.

Authors:  H Namba; K Matsuo; J A Fagin
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

View more
  9 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter.

Authors:  Marcin Barczyński; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Filip Gołkowski; Stanisław Cichoń; Wojciech Nowak
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 3.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

Review 4.  [Total thyroidectomy for multinodular goiter].

Authors:  T J Musholt
Journal:  Chirurg       Date:  2010-07       Impact factor: 0.955

5.  Five-year follow-up of a randomized clinical trial of unilateral thyroid lobectomy with or without postoperative levothyroxine treatment.

Authors:  Marcin Barczyński; Aleksander Konturek; Filip Gołkowski; Alicja Hubalewska-Dydejczyk; Stanisław Cichoń; Wojciech Nowak
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 6.  Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature.

Authors:  Jacob Moalem; Insoo Suh; Quan-Yang Duh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy.

Authors:  Sibel Ertek; Reyhan Ünlü Ersoy; Cüneyd Anıl; Ozgür Demir; Murat Faik Erdoğan; Sevim Güllü; Dilek Berker; Kamile Gül; Uğur Unlütürk; Gürbüz Erdoğan
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

8.  Role of cytological characteristics of benign thyroid nodules on effectiveness of their treatment with levothyroxine.

Authors:  Mustafa Cesur; Mehtap Akcil; Sibel Ertek; Rifat Emral; Safak Bulut; Sevim Gullu; Demet Corapcioglu
Journal:  Arch Med Sci       Date:  2013-12-26       Impact factor: 3.318

9.  Nontoxic Multinodular Goitre and Incidental Thyroid Cancer: What Is the Best Surgical Strategy?-A Retrospective Study of 2032 Patients.

Authors:  Krzysztof Kaliszewski; Beata Wojtczak; Jędrzej Grzegrzółka; Jacob Bronowicki; Sawsan Saeid; Bartłomiej Knychalski; Zdzisław Forkasiewicz
Journal:  Int J Endocrinol       Date:  2018-05-14       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.